These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16470853)

  • 1. A case of methotrexate embryopathy with holoprosencephaly, expanding the phenotype.
    Seidahmed MZ; Shaheed MM; Abdulbasit OB; Al Dohami H; Babiker M; Abdullah MA; Abomelha AM
    Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):138-42. PubMed ID: 16470853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fetal methotrexate and misoprostol exposure: the past revisited.
    Wheeler M; O'Meara P; Stanford M
    Teratology; 2002 Aug; 66(2):73-6. PubMed ID: 12210010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful rescue of an early interstitial pregnancy after failed systemic methotrexate treatment: a case report.
    Lin YS; Chen CL; Yuan CC; Wang PH
    J Reprod Med; 2007 Apr; 52(4):332-4. PubMed ID: 17506378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failed methotrexate termination of pregnancy: a case report.
    Goffman D; Cole DS; Bobby P; Garry DJ
    J Perinatol; 2006 Oct; 26(10):645-7. PubMed ID: 17006526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclophosphamide, methotrexate, and cytarabine embropathy: is apoptosis the common pathway?
    Vaux KK; Kahole NC; Jones KL
    Birth Defects Res A Clin Mol Teratol; 2003 Jun; 67(6):403-8. PubMed ID: 12962283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Holoprosencephaly and genitourinary anomalies in fetal methotrexate syndrome.
    Corona-Rivera JR; Rea-Rosas A; Santana-Ramírez A; Acosta-León J; Hernández-Rocha J; Miguel-Jiménez K
    Am J Med Genet A; 2010 Jul; 152A(7):1741-6. PubMed ID: 20578136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype.
    Lopez-Rangel E; Van Allen MI
    Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):919-23. PubMed ID: 16265639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult and two children with fetal methotrexate syndrome.
    Bawle EV; Conard JV; Weiss L
    Teratology; 1998 Feb; 57(2):51-5. PubMed ID: 9562676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate embryopathy after exposure to low weekly doses in early pregnancy.
    Martín MC; Barbero P; Groisman B; Aguirre MÁ; Koren G
    Reprod Toxicol; 2014 Jan; 43():26-9. PubMed ID: 24513926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of fetal valproate syndrome with new features expanding the phenotype.
    Seidahmed MZ; Miqdad AM; Al-Dohami HS; Shareefi OM
    Saudi Med J; 2009 Feb; 30(2):288-91. PubMed ID: 19198722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Visual field changes in methotrexate therapy. Case report and review of the literature.
    Sbeity ZH; Baydoun L; Schmidt S; Loeffler KU
    J Med Liban; 2006; 54(3):164-7. PubMed ID: 17190135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Burkitt's lymphoma during pregnancy.
    Lam MS
    Ann Pharmacother; 2006 Nov; 40(11):2048-52. PubMed ID: 17062832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremity Findings of Methotrexate Embryopathy.
    Mantilla-Rivas E; Brennan A; Goldrich A; Bryant JR; Oh AK; Rogers GF
    Hand (N Y); 2020 Jan; 15(1):NP14-NP21. PubMed ID: 31542953
    [No Abstract]   [Full Text] [Related]  

  • 14. Teratogenicity studies with methotrexate, aminopterin, and acetylsalicylic acid in domestic cats.
    Khera KS
    Teratology; 1976 Aug; 14(1):21-7. PubMed ID: 960008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Holoprosencephaly as a possible embryonic alcohol effect.
    Ronen GM; Andrews WL
    Am J Med Genet; 1991 Aug; 40(2):151-4. PubMed ID: 1897567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moebius syndrome and holoprosencephaly following exposure to misoprostol.
    Pirmez R; Freitas ME; Gasparetto EL; Araújo AP
    Pediatr Neurol; 2010 Nov; 43(5):371-3. PubMed ID: 20933185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis of methotrexate embryopathy.
    Chapa JB; Hibbard JU; Weber EM; Abramowicz JS; Verp MS
    Obstet Gynecol; 2003 May; 101(5 Pt 2):1104-7. PubMed ID: 12738117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition in adult patients of malformations induced by folic-acid antagonists.
    Reich EW; Cox RP; Becker MH; Genieser NB; McCarthy JG; Converse JM
    Birth Defects Orig Artic Ser; 1978; 14(6B):139-60. PubMed ID: 728558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother.
    Buckley LM; Bullaboy CA; Leichtman L; Marquez M
    Arthritis Rheum; 1997 May; 40(5):971-3. PubMed ID: 9153561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.